Skip to main content
. 2020 Dec 4;4(23):5951–5957. doi: 10.1182/bloodadvances.2020002858

Table 2.

Events for EFS analysis in the intent-to-treat population

Short maintenance (n = 82) Long maintenance (n = 83)
Events 54 (65.9) 53 (63.9)
Censored 28 (34.1) 30 (36.1)
Type of event
 Death 3 (5.6) 4 (7.6)
 Disease progression or relapse 47 (87.0) 35 (66.0)
 Secondary malignancy 4 (7.4) 7 (13.2)
 Unacceptable toxicity 0 (0) 6 (11.3)
 Initiation of nonprotocol anticancer treatment 0 (0) 1 (1.9)

Data are n (%).